Q32 Bio Inc

Healthcare · Biotechnology

8.20$ -0.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Q32 Bio Inc (QTTB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 116 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet QTTB
Line item	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	138	129	270	268	259	233	341	317	311	289	258	228	264	235	259	231	212	311	285	263	62	198	169	54	47	152	124	105	92	79	66	58	62	64	116
Current Assets	–	132	120	262	246	222	191	299	274	267	238	210	181	220	192	218	192	192	262	238	213	47	154	131	39	29	138	112	94	82	69	58	51	55	57	110
Cash	–	52	46	95	36	38	41	116	78	54	143	168	178	217	104	116	96	108	248	176	43	44	39	77	36	26	116	98	89	78	65	55	49	48	51	106
Cash & Short-Term Investments	–	130	117	256	238	215	188	296	270	262	235	207	178	217	189	213	188	156	256	226	201	44	150	127	36	26	135	108	89	78	65	55	49	48	51	106
Receivables	–	–	–	–	–	–	–	–	0.3	0.4	0.4	0.4	0.4	0.4	0.3	0.2	0.1	–	–	–	1.1	1.1	–	0.7	0.7	0.8	0.6	0.6	0.6	0.6	0.6	0.6	0.6	4.8	5.4	2.4
Inventory	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-1.1	-1.1	–	2.1	2.1	2.1	2.1	-0.6	–	–	–	–	–	–	–	–
Total Liabilities	–	39	41	44	56	64	59	56	59	52	62	64	58	68	34	34	32	42	45	44	54	192	46	50	210	230	104	91	86	87	83	78	76	20	17	10.0
Current Liabilities	–	8.9	9.4	11	19	25	18	15	19	12	17	20	17	23	18	20	19	17	21	21	25	58	19	23	72	14	33	17	14	16	15	12	11	11	11	5.4
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	2.3	2.4	2.5	2.5	2.3	2.1	2.0	0.2	0.4	0.4	1.5	33	1.6	1.7	38	1.4	4.6	1.4	2.6	3.7	5.3	6.9	6.9	6.9	7.0	0.7
Accounts Payable	–	2.5	3.8	5.0	11	16	12	8.3	8.8	2.6	7.4	7.1	3.3	4.7	4.9	5.7	3.5	2.4	9.9	3.8	4.8	1.4	3.6	3.4	1.8	3.5	5.0	2.5	1.3	3.0	2.7	0.9	1.0	0.9	0.7	1.6
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	5.1	5.1	–	5.0	5.0	9.4	9.4	13	11	9.6	8.0	6.5	5.0	3.5	1.9	–
Shareholders' Equity	–	98	88	227	213	195	174	285	258	259	227	195	170	196	201	225	199	170	266	240	209	-131	152	119	-156	-183	49	34	18	5.7	-4.0	-12	-18	42	46	106
Retained Earnings	–	-40	-51	-64	-78	-97	-120	-146	-176	-200	-235	-270	-299	-328	-329	-360	-391	-424	-332	-361	-395	-133	-458	-493	-160	-187	-186	-203	-221	-235	-246	-255	-263	-205	-213	-222
Shares Outstanding	2.1	2.1	2.1	2.0	2.1	2.1	2.1	2.4	2.4	2.4	2.5	2.5	2.5	2.7	2.8	3.1	3.2	3.2	3.2	3.2	3.2	12	12	12	12	12	12	12	12	11	12	12	12	13	14	14

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings